Formulation and Evaluation of Fast Disintegrating Tablets of Caffeine by Using Effervescent Formulation Approach

Similar documents
International Journal of Pharmacy

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

Karnataka Department of Pharmaceutical Technology, H.K.E. Society s College of Pharmacy, Gulbarga, Karnataka ABSTRACT KEYWORDS:

Formulation and Evaluation

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

Formulation and evaluation of fast dissolving tablet of aceclofenac

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

Available Online through Research Article

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Global College of Pharmacy, Kahnpur Khui, Tehsil Anandpur Sahib, Distt.- Ropar, Punjab, India

Formulation and evaluation of sublingual tablets of lisinopril

Biowaiver Study on Prednisolone Tablets 5 mg in Three Different Brands. Marketed in Sudan. Safaa Mohamed *, Tilal Elsaman

EFFECT OF SUPERDISINTEGRANTS ON RELEASE OF DOMPERIDONE FROM FAST DISSOLVING TABLETS

Pavan K et al IJARPB: 2013, 3(2), ISSN: Available online on Research Article

B. Jayakar et. al. FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF CELECOXIB R. Margret Chandira, Shyam Sharma, Debjit Bhowmik, B.

Available Online through

Formulation and evaluation of immediate release salbutamol sulphate

DESIGN, DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING TABLET OF NEBIVOLOL HCL

INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

Optimization of valsartan tablet formulation by 2 3 factorial design

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

FORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING AGENTS

Formulation and evaluation of oro-dispersible tablets of lafutidine

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL

Scholars Research Library. Formulation Development of Pioglitazone Tablets Employing β Cyclodextrin- Poloxamer 407- PVP K30: A Factorial Study

Formulation and evaluation of intraorally fast dissolving tablet of olmesartan medoxomil

Int. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN:

Received on: Accepted on:

Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison with other Superdisintegrants

Comparative in-vitro evaluation of four different brands of metformin HCl available in Kanpur district, India

Scholars Research Library. Formulation and evaluation of rizatriptan benzoate orodispersible tablets

Formulation and Evaluation of Glicazide Mouth Dissolving Tablets

FORMULATION DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING TABLET OF TRAMADOL HYDROCHLORIDE

FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF ORALLY DISINTEGRATING TABLETS OF AMLODIPINE BESYLATE

DESIGN AND EVALUATION OF COST EFFECTIVE ORODISPERSIBLE TABLETS OF DIETHYLCARBAMAZINE CITRATE BY EFFERVESCENT METHOD

DESIGN AND CHARACTERIZATION OF FLOATING TABLETS OF ANTI-DIABETIC DRUG

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN:

IJRPC 2014, 4(2), Vinod Kumar et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

FORMULATIO A D EVALUATIO OF ORO DISPERSIBLE TABLETS OF CLO AZEPAM BY DIRECT COMPRESSIO METHOD

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

Formulation and Evaluation of Etoricoxib Oro Dispersable Tablets by Direct Compression Method

Formulation Design and Optimization of Fast Disintegrating Lorazepam Tablets by Effervescent Method

Formulation and Evaluation of Oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants

Formulation and Evaluation of Rosuvastatin Immediate Release Tablets 10 Mg

OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105

Journal of Chemical and Pharmaceutical Research, 2015, 7(5): Research Article

Formulation, Optimization and Evaluation of Mouth Dissolving Tablet of Zidovudine

Available online through ISSN

Comparative evaluation of modified starches in different tablet formulations as disintegrants

Formulation and Evaluation of Amlodipine besylate orally disintegrating tablet

DESIGNING OF ORODISPERSIBLE TABLET OF DIETHYL CARBAMAZINE CITRATE FOR THE TREATMENT OF FILARIASIS

M.Vijaya Laxmi et al., Asian Journal of Pharmaceutical Technology & Innovation, 03 (10); 2015; Research Article

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

Chemate and Chowdary, IJPSR, 2012; Vol. 3(7): ISSN:

DEVELOPMENT AND IN VITRO EVALUATION OF SUSTAINED RELEASE FLOATING MATRIX TABLETS OF METFORMIN HYDROCHLORIDE

FORMULATION & EVALUATION OF ORALLY DISINTEGRATING TABLET OF IBUPROFEN FOR PAEDIATRIC USE

Research Article Formulation and In-Vitro Evaluation of Fast Disintegrating Rosiglitazone Sublingual Tablets

International Journal of Pharma and Bio Sciences V1(1)2010 FORMULATION AND EVALUATION OF ROSIGLITAZONE MOUTH DISSOLVING TABLET

Research Journal of Pharmaceutical, Biological and Chemical Sciences

ISSN: Available online Journal of Global Trends in Pharmaceutical Sciences. Research Article

FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES

Feasibility of using natural gums for development of sustained release matrix tablet of itopride

Design and development of fast Melting Tablets of Terbutaline Sulphate

Development and validation of analytical methods for estimation of imatinib mesylate in bulk and solid dosage forms by UV spectroscopy

Volume: I: Issue-2: Aug-Oct ISSN NOVEL APPROACH IN FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF ONDANSETRON HYDROCHLORIDE

FAST DISPERSING TABLETS REVIEW Chetan V. Suryawanshi*, N. A. Gujrathi, B. R. Rane

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS

Pharmacologyonline 2: (2011) ewsletter Mehul et al. FORMULATIO A D EVALUATIO OF ORODISPERSIBLE TABLETS OF PHE IRAMI E MALEATE

COMPARATIVE IN VITRO EVALUATION OF COMMERCIALLY AVAILABLE PANTOPRAZOLE DELAYED RELEASE TABLETS

Scholars Research Library. Formulation and evaluation of buccoadhesive tablet of Atenolol

Int. J. Pharm. Sci. Rev. Res., 33(1), July August 2015; Article No. 12, Pages: 55-61

K. Ravi Shankar et al. /BioMedRx 2013,1(3), Available online through

Design and In-vitro Evaluation of Silymarin Bilayer Tablets

PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE VEHICLE IN TABLET FORMULATIONS

Development and characterization of orodispersible tablets of famotidine containing a subliming agent

CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

Available online Research Article

Formulation And Evaluation Of Flurbiprofen Matrix Tablets For Colon Targeting

Formulation Development of Nimesulide Tablets by Wet Granulation and Direct Compression Methods Employing Starch Citrate

Formulation and evaluation of oral dispersible tablets of aripiprazole

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

Effect of Polymer Concentration and Viscosity Grade on Atenolol Release from Gastric Floating Drug Delivery Systems

Formulation and Evaluation of Mouth Dissolving Sublingual Tablets of Cimetidine to Treat Abdominal Cramps

Scholars Research Library

Venkateswara Rao et.al Indian Journal of Research in Pharmacy and Biotechnology ISSN: (Print) ISSN: (Online)

Adimoolam Senthil et al. IRJP 2 (1)

Received on: Accepted on:

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

REVISION OF MONOGRAPH ON TABLETS. Tablets

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

ENHANCEMENT OF SOLUBILITY, DISSOLUTION RATE AND BIOAVAILABILITY OF RITONAVIR BY CYCLODEXTRINS AND SOLUTOL HS15 - A FACTORIAL STUDY

International Journal of Chemistry and Pharmaceutical Sciences

Transcription:

Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 212, 4 (5):149-1494 (http://scholarsresearchlibrary.com/archive.html) ISSN 975-571 USA CODEN: DPLEB4 Formulation and Evaluation of Fast Disintegrating Tablets of Caffeine by Using Effervescent Formulation Approach Neha Tomar, Mohit Tomar, Neha Gulati and Upendra Nagaich Dept. of Pharmaceutics, BIT-School of Pharmacy, By-Pass Road, Partapur, Meerut-2513 (U.P.) ABSTRACT In recent decades, a variety of pharmaceutical research has been conducted to develop new dosage forms. Among them, the fast disintegrating tablet (FDTs) is one of the most widely employed commercial products to facilitate ease of medication. Upon introduction into the mouth, these tablets dissolve or disperse in the mouth in the absence of additional water and the active pharmaceutical ingredients are readily released from the dosage form. The popularity and usefulness of these formulations resulted in development of several ODT technologies. These tablets are convenient for young children, elderly and patients with swallowing difficulties, and in situations where a potable liquid (water) is not available. The popularity and usefulness of these formulations resulted in development of several ODT technologies. Caffeine acts as a central nervous system stimulant produces increased wakefulness, faster and clearer flow of thought, increased focus, and better general body coordination. Soluble effervescent tablets get dissolved quickly when put in water to give a solution which can be easily consumed by patients with temporarily warding off drowsiness and restoring alertness. The present investigation describes the formulation methodology, evaluation parameters and future aspects of fast disintegrating tablets (FDTs). Key Words: Fast disintegrating tablets (FDTs), Effervescence, Caffeine, Sodium Bicarbonate, Citric Acid, Sorbitol. INTRODUCTION Fast dissolving tablets are continuously gaining great success in the pharmaceutical market. The most popular solid dosage forms are tablets and capsules but the major drawback of these dosage forms for some patients is the difficulty to swallow it [1]. FDTs are not only preferable for people who have swallowing difficulties, but also are ideal for active people. Suitable drug candidates for such systems include neuroleptics, cardiovascular agents, analgesics, antiallergics and drugs for erectile dysfunction [2]. Such a tablet disintegrates instantaneously when placed on tongue, releases the drug that dissolves or disperses in the saliva. As the oral mucosa is highly vascularized, drugs that are absorbed through the oral mucosa can directly enter into the systemic circulation, bypassing the gastrointestinal tract (GIT) and therefore first pass metabolism in the liver. This result to a rapid onset of action, and greater bioavailability of the drug than those observed from conventional tablet dosage form [3,4]. There are several salient features of fast dissolving drug delivery system. These are ease of administration to the patient who cannot swallow, such as the pediatric, geriatric & psychiatric patients, elderly, stroke victims, bedridden patients, patient affected by renal failures. There is no need of water to swallow the dosage form, which is highly convenient feature for patients who are traveling. It also undergoes rapid dissolution and absorption of the drug produces quick onset of action. These also provide good mouth feel property that helps to change the perception of 149

Neha Tomar et al Der Pharmacia Lettre, 212, 4 (5):149-1494 medication as bitter pill particularly in pediatric patient. Pregastric absorption can result in improved bioavailability and as a result of reduced dosage; improve clinical performance through a reduction of unwanted effects [5]. MATERIALS AND METHODS Materials: Caffeine was obtained as gift sample from Merck Lab Mumbai, India. Sorbitol, citric acid, Sodium bicarbonate, sodium saccharine, talc and magnesium stearate were purchased from CDH, New Delhi. All the ingredients used were of analytical grade. Methodology: Preparation of Fast Dissolving Tablets Different formulations of caffeine were produced using different concentration of sodium bicarbonate and citric acid as effervescence producing agent by effervescent technique. All the ingredients (except purified talc) were accurately weighed and sifted through # 44 mesh separately. The drug and diluents were mixed in small proportion in geometric order. The ingredients after sifting through #44 mesh were thoroughly mixed.the tablets of weight 4 mg were prepared by directly compressed method on a 1- station rotary tablet machine (Single punching Machine) using 7 mm round flat punches. The tablets were prepared according to the formulae shown in Table 1 [6]. Characterization of Caffeine loaded FDTs All the tablets were evaluated for following different parameters which includes: Thickness and diameter Thickness and diameter of tablets were determined using Vernier caliper. Randomly five tablets from each batch were selected and used, and an average value was calculated [7]. Friability The friability of a sample of randomly selected ten tablets was measured by using the Roche Friabilator (Electro Lab). Ten tablets were weighed and rotated at 25 rpm for 4 minutes. Tablets were dusted and re-weighed. Tablets were reweighed after removal of fines (dedusted) and the percentage of weight loss was calculated and the limit of the percent friability was kept below 1%. [7]. Hardness For each formulation, the hardness of five tablets was determined using the Monsanto Hardness tester (Cadmach). The limit for crushing strength of the tablets was kept in range of 3-5 kg/cm 2 [8]. Weight variation Twenty tablets were randomly selected from each formulation batch and individually weighed from electronic precision balance (CTG 32B-3). The average weight of the selected tablets was measured and comparing the individual tablet weights to the average. The percentage weight variation was calculated and then compared with specification as per I.P. shown in Table 2 [9]. Water absorption ratio A piece of tissue paper folded twice was put in a small Petri dish (internal diameter = 6.5 cm) containing 5 ml of distilled water. The weight of the tablet before keeping in the petridish was noted (Wb). Completely wetted tablet from the petridish was taken and reweighed (Wa). The water absorption ratio R can be measured by the following formula. R= (Wa Wb)/Wa 1 Where, Wa is the weight of the tablets before the test and Wb is the weight of the tablet after water absorption [9]. In vitro Disintegration test The disintegration time was measured using disintegration test apparatus. One tablet was placed in each tube of the basket. The basket with the bottom surface made of a stainless steel screen (mesh no. 1) was immersed in water bath at 37 ± 2ºC. The time required for complete disintegration of the tablet in each tube was determined using a 1491

Neha Tomar et al Der Pharmacia Lettre, 212, 4 (5):149-1494 stop watch. To be complied with the Pharmacopoeial standards, dispersible tablets must disintegrate within 3 min when examined by the disintegration test for tablets. In vitro dispersion time In vitro dispersion time was measured by dropping a tablet in a beaker containing 5 ml of phosphate buffer solution ph 6.8 at 37±.5 C. Three tablets from each formulation were randomly selected and in vitro dispersion time was recorded [1]. Drug content For the drug content ten tablets were weighed, crushed and powdered. An amount of the powder equivalent to 1 mg of caffeine was taken and dissolved in 1 ml of ph 6.8 buffer, filtered, diluted suitably and analyzed for drug content at 271 nm using UV-Visible double beam spectrophotometer (UV 221 SYSTRONICS) [1]. Dissolution study In vitro dissolution of caffeine loaded fast dissolving tablets was studied in USP type-ii dissolution test apparatus (LABINDIA, DS 8) employing a paddle stirrer at 5 rpm using 9 ml of ph 6.8 phosphate buffer as dissolution medium at 37±.5ºC. One tablet was used in each test. Aliquots of dissolution medium (5 ml) were withdrawn at specified intervals of time and analyzed for drug content by measuring the absorbance. The volume withdrawn at each time interval was replaced with fresh quantity of dissolution medium. Cumulative percent of caffeine released was calculated and plotted against time [11]. Wetting time To perform this test, a piece of tissue paper folded twice was placed in a small petridish (internal diameter 6.5 cm) containing 6 ml of distilled water. A tablet was placed on the paper, and the time for complete wetting was noted. Three trials for each formulation batch and the standard deviation were also measured [12]. RESULTS AND DISCUSSION Caffeine loaded fast dissolving tablets (FDTs) were formulated and optimized via effervescent technique. The prepared tablets were evaluated for all physical parameters which were found to be within the acceptable limits. Formulations were white in color with no odor and smooth circular surface. Weight variation of all formulations was found to be within the range of 399mg to 44mg. A tablet requires certain amount of hardness to withstand the mechanical shocks during handling, packaging and at the time of application. The hardness of the prepared tablet varied from 3.4 to 4.2 Kg/cm 2 which show good mechanical strength with sufficient hardness. The friability of all the formulation was found to be less than 1. % which was within the official acceptable limits. The results shows resistance to loss of weight indicates the tablet s ability to withstand abrasion in handling, packaging and shipment. The wetting time for all the formulations was found to be less than one minute for the optimized one which indicates quicker disintegration of the tablet. The disintegration time of the tablets varied from 58 to 4 seconds. The tablets with increasing effervescent agents may disintegrate faster. The drug content of all the formulations varied from 94.62 to 98.6%. The cumulative in vitro drug release was found to be 95.58% to 99.83% at the end of fifteen minutes. The formulation code F5 shows maximum release of 98.6% within 15min. Formulation F5 is considered as promising formulation and the drug release followed the controlled mechanism of Higuchi kinetics (r 2 =.9845). Table 1: Formulation of FDTs by Effervescent Method Formulation ingredients FORMULATION CODE (mg/tablet) F1 F2 F3 F4 F5 Drug 1 1 1 1 1 Sorbitol 25 24 23 22 21 Sodium bicarbonate 3 4 5 6 7 Citric acid 1 1 1 1 1 Saccharine 5 5 5 5 5 Magnesium Stearate 5 5 5 5 5 Total 4 4 4 4 4 1492

Neha Tomar et al Der Pharmacia Lettre, 212, 4 (5):149-1494 Table 2: Weight variation specification as per I.P. Average Weight of Tablets % deviation 8 mg or less ±1 More than 8 mg but less than 25 mg ±7.5 25 mg or more ±5 Table 3: Evaluation Parameters Evaluation Parameter Thickness (mm) Diameter(mm) Shape Hardness (kg/cm 2 ) Friability (%) Weight variation Wetting Time (Seconds) Water Absorption Ratio Disintegration Time (Se In vitro dispersion Time Drug content (%) Formulation code F1 F2 F3 F4 2.9±.9 3.±.12 3.2±.15 2.9±.13 1.8±.2 1.9±.14 11.1±.15 1.9±.16 Circular Circular Circular Circular 3.4±.15 3.6±.13 3.8±.9 4.1±.5.52±.1.6±.1.71±.9.5±.7 44±1.51 43±1.18 42±1.45 41±1.59 ) 37±1.8 32±1.5 31±1.7 28±1.2 o (%) 55.31±.7 63.47±.69 68.44±.92 74.74±.71 econds) 58±2.18 54±1.47 49±2.18 46±1.5 e 75±2.3 12±3. 66±2.8 55±2.5 94.62±.51 96.68±.25 97.71±.28 98.26±.35 (n=3) F5 3.1±.18 11.2±.23 Circular 4.2±.2.66±.6 399±.58 23±1. 8.2±.66 4±1.5 52±2.58 98.6±.28 Table 4: Data for In vitro cumulative percent drug release of caffeine loaded FDTs Cumulative Percent (%) drug release Time (min) 3 F1 3.45±.4 F2 34.11±.71 F3 38.33±.41 F4 41.1±.26 F5 43.16±.32 6 36.12±.23 39.32±.43 43.5±.49 47.1±.14 53.35±.52 9 54.35±.81 58.4±.71 69.33±.62 73.5±.56 81.53±.45 12 78.44±.65 82.24±.74 84.45±.39 86.44±.41 88.4±.86 15 87.6±.72 91.55±.36 93.13±.48 94.1±.54 98.6± ±.35 (n=3) Figure 1: Comparison of wetting and disintegration time of Caffeine Loaded FDTs 1493

Neha Tomar et al Der Pharmacia Lettre, 212, 4 (5):149-1494 Figure 2: Graph representing in vitro cumulative percent drug release of caffeine loaded FDTs CONCLUSION The fast dissolving tablets have potential advantages over conventional dosage forms as it avoids the hepatic first pass metabolism so increases the systemic availability of drug i.e caffeine. Fast dissolving tablets of caffeine is successfully prepared by using effervescent technique. By using various technologies and the multiple applications of fast dissolving tablets will definitely fulfill the patient`s need as there is low dosing, rapid onset of action, increased bioavailability, low side effect which increase its popularity in the near prospect. Results suggests that the FDTs containing Sodium bicarbonate and Sorbitol in the ratio of 1:3 (F5) shows best results in terms of cumulative percent drug release, hardness and disintegration time. Results concluded that disintegration and wetting time get decreased by increasing the concentration of effervescent agents. REFERENCES [1] RS Shekhar; T Vedavathi. RJPBCS, 212, 3,1,771-792. [2] RK Chang; X Guo; BA Burnside; RA Couch. Pharm.Technol, 2, 24, 52 58. [3] S Corveleyn; JP Remon; Int. J.Pharm, 1997, 152, 215 225. [4] TK Giri; KD Tripathi; R Majumdar; Int J Pharmacy and Pharm Sci, 21, 2, 3, 38-42. [5] Arun Arya; And Amrish Chandra; Der Pharmacia Lettre, 21, 2, 2, 35-361. [6] D Kaushik; TR Saini; H Dureja. Indian Drugs, 24, 41, 7, 41-412. [7] Ravikumar et al. Der Pharmaciaa Lettre 21, 2, 1, 22-236. [8] S Jacob; A Shirwaikar; A Nair. Drug Dev Ind Pharm, 29, 35,3,321 8. [9] R Goyal; SS Baghel; A Pathak; K Sharma; G Tiwari; R Shivhare. WJPR, 212,1,3,576-59. [1] AK Gupta; A Mittal; KK Jha. The Pharma Innovation, 212,1,1,1-8. [11] DN Kumar; SA Raju; SB Shirsand.. International Journal Of Pharma And Bio Sciences 21,1,1,1-7. [12] Y Bi; H Sunada; Y Yonezawa; K Danjo K; A Otruka; K Lida. Chem Pharm Bull, 1996, 44,11,2121-7. 1494